Ultrastructural Effects of Oritavancin on Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

The ultrastructural effects of the lipoglycopeptide oritavancin on methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE) were examined by transmission electron microscopy. Oritavancin but not vancomycin induced aberrant septum formation and loss of staining of nascent septal cross walls in MRSA. Septal distortions were also observed in VRE exposed to oritavancin.

Knowledge Graph

Similar Paper

Ultrastructural Effects of Oritavancin on Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus
Antimicrobial Agents and Chemotherapy 2009.0
Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
Antimicrobial Agents and Chemotherapy 2010.0
Oritavancin Kills Stationary-Phase and BiofilmStaphylococcus aureusCells In Vitro
Antimicrobial Agents and Chemotherapy 2009.0
Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
Antimicrobial Agents and Chemotherapy 2009.0
Impact of Human Serum Albumin on Oritavancin In Vitro Activity against Enterococci
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus , S . epidermidis , and Enterococcus faecalis Strains
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
Antimicrobial Agents and Chemotherapy 2008.0
Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of Telavancin against a Contemporary Worldwide Collection of Staphylococcus aureus Isolates
Antimicrobial Agents and Chemotherapy 2010.0
Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
Antimicrobial Agents and Chemotherapy 2010.0